Sperlix Pharma began in 2023 with a drive to meet the growing need for high-quality, neuropsychiatric medications. The primary goal is to improve patient's quality of life who are dealing with neurological conditions. We're pleased with the improved interaction with our supply chain and the cohesiveness of our team. Through supplying neuro goods worldwide, our organization, which is X-certified, guarantees that we will set a new standard for success.
The drugs have undergone rigorous testing and are made using cutting-edge technology. We won't allow more to be shipped unless it passes our stringent quality checks, and our dedicated staff is equally committed to maintaining that standard. Maintaining happy clients is our first concern, therefore we're prepared to go the extra mile if necessary. Pledge to make the country a healthier and more active place to live, and give us an opportunity to earn your satisfaction with our service.
| Year of Establishment | 2023 |
|---|---|
| Total Number of Employees | 15 |
| Annual Turnover | 3 CR |
| GST No. | 06ABICS2889P1ZE |
| Company Registration No. | U24230HR2022PTC102875 |
